EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A novel dual probe-based method for mutation detection using isothermal amplification

Nidhi Nandu iD, Michael Miller, Yanhong Tong, Zhi-Xiang Lu iD

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0309541 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Nidhi Nandu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Revvity, Inc., Waltham, MA, United States of America. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Nucleic Acid Amplification Techniques, Mutation, Rifampin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Revvity Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cost efficient and rapid detection tools to detect mutations especially those linked to drug-resistance are important to address concerns of the rising multi-drug resistance infections. Here we integrated dual probes, namely a calibrator probe and an indicator probe, into isothermal amplification detection system. These two probes are designed to bind distinct regions on the same amplicon to determine the presence or absence of mutation. The calibrator probe signal is used as an internal signal calibrator for indicator probe which detects the presence or absence of the mutation. As an illustrative example, we evaluated the applicability of this dual probe method for detecting mutations associated with rifampicin (RIF) drug resistance at codons 516, 526 and 531 of the rpo B gene in Mycobacterium tuberculosis . In this assessment, we examined 127 artificial samples comprising wild types and mutants with single or multiple mutations. Our results demonstrated 100% accuracy for both wild types and mutants for mutations at codons 526 and 531. As regards to mutations at codon 516, the wild type was identified with 100% accuracy, while the mutants were identified with 95% accuracy. Moreover, when we extended our evaluation to include clinical MTB strains and the Zeptometrix MTB Verification panel, our method achieved 100% accuracy (5 out of 5) in identifying wild-type strains. Additionally, we successfully detected a RIF-resistant strain with mutations at codon 531 of the rpo B gene in Zeptometrix verification panel. Our isothermal mutation detection system, relying on dual probes exhibits a versatile approach. With the capability to identify mutations without prior knowledge of their specific mutation direction, our dual-probe method shows significant promise for applications in drug resistance nucleic acid testing, particularly in resource-limited settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisNucleic Acid Amplification TechniquesMutationRifampinBacterial ProteinsDNA-Directed RNA PolymerasesHumansDrug Resistance, BacterialCodonTuberculosis, Multidrug-ResistantMolecular Diagnostic Techniques

Substanzen

RifampinBacterial ProteinsDNA-Directed RNA PolymerasesrpoB protein, Mycobacterium tuberculosisCodon

Autor:innen und Institutionen

  • Revvity, Inc., Waltham, MA, United States of America.

ORCID-Profile: Nidhi Nandu, Zhi-Xiang Lu

Förderung

  • Revvity Inc

Zitieren

APA

Nandu, N., Miller, M., Tong, Y., & Lu, Z. X. (2024). A novel dual probe-based method for mutation detection using isothermal amplification. PLOS ONE. https://doi.org/10.1371/journal.pone.0309541

Vancouver

Nandu N, Miller M, Tong Y, Lu ZX. A novel dual probe-based method for mutation detection using isothermal amplification. PLOS ONE. 2024. doi:10.1371/journal.pone.0309541

BibTeX
@article{Nandu2024,
  author = {Nandu, Nidhi and Miller, Michael and Tong, Yanhong and Lu, Zhi-Xiang},
  title = {A novel dual probe-based method for mutation detection using isothermal amplification},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0309541}
}
Kostenlos starten →